Biomarkers Predicting Venetoclax Sensitivity and Strategies for Venetoclax Combination Treatment
Author(s) -
Haijiao Zhang,
Beth Wilmot,
Daniel Bottomly,
Stephen E. Kurtz,
Christopher A. Eide,
Alisa Damnernsawad,
Kyle A. Romine,
Shyam A. Patel,
Brian J. Druker,
Schan K Mcweeney,
Ravindra Majeti,
Jeffrey W. Tyner
Publication year - 2018
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2018-175
Subject(s) - venetoclax , azacitidine , medicine , myeloid leukemia , oncology , cancer research , decitabine , leukemia , immunology , biology , chronic lymphocytic leukemia , gene expression , genetics , gene , dna methylation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom